Adult male and female C57BL/6 mice sourced from The Jackson Laboratory or Charles River Laboratories served as the primary tissue source for a newly identified glucose uptake pathway in skeletal muscle, according to a study.
Researchers found that working skeletal muscles take up glucose without relying on insulin.
This pathway, designated as mSGLT due to its shared properties with the Sodium Glucose Linked Transporter family, operates independently of the abundant GLUT4 transporter. Unlike GLUT4, mSGLT requires Na,K-ATPase-$alpha2$ activity and transports $alpha$-methyl-D-glucoside ($alpha$MDG), a glucose derivative handled by SGLTs but ignored by GLUT4.
For tissue extraction, workers fasted the animals for 3 hours, anesthetized them with 2.5% Avertin at 17 milliliters per kilogram, and euthanized them by cervical dislocation.
Frozen human vastus lateralis muscle samples supplied by the University of Kentucky Center for Muscle Biology provided additional comparative material. Uptake measurements on isolated extensor digitorum longus muscles utilized specialized equilibration and uptake buffers maintained at 32 degrees Celsius, while researchers measured carbon-13, rubidium, and phosphorus using inductively coupled plasma mass spectrometry.
The Equilibration Buffer contained 118 millimolar NaCl, 4.7 millimolar KCl, 2.5 millimolar CaCl2, 1.2 millimolar MgCl2, 1.2 millimolar NaH2PO4, 11 millimolar D-glucose, and 25 millimolar NaHCO3, gassed with 95% oxygen and 5% carbon dioxide.
Sodium-free wash buffers used either 15 millimolar Tris-Cl, 2.5 millimolar CaCl2, 1.2 millimolar MgCl2, and 263 millimolar sucrose, or 10 millimolar Tris-Cl, 2.8 millimolar KCl, 1.2 millimolar KH2PO4, 1.3 millimolar CaCl2, and 1.2 millimolar MgCl2. All other chemicals utilized in the study were trace metal grade, sourced from Sigma Aldrich or Thermo Fisher Scientific.
The mSGLT pathway and standard GLUT transport pathways operate independently and additively within the tissue. In addition to exercise, mSGLT imports glucose under conditions of adrenergic stimulation, which suppresses pancreatic insulin release and lowers muscle insulin sensitivity.
SGLT2-specific antibodies recognize a protein in muscle tissue that matches the size of kidney SGLT2 and localizes to muscle t-tubules alongside Na,K-ATPase-$alpha2$ and MAP17. Skeletal muscles do not express a full-length transcript of Slc5a2, and SGLT2-specific inhibitors fail to block mSGLT with high affinity, pointing to a potential muscle-specific variant driven by post-transcriptional or post-translational mechanisms.
The Jackson Laboratory, founded in 1929 in Bar Harbor, Maine, operates as an independent, non-profit biomedical research institution. It has grown into one of the world’s largest suppliers of laboratory mice, providing more than 13,000 unique strains to over 2,400 organizations across 68 countries.
The institution is recognized for establishing that cancer is a genetic disorder and for its role in pivotal medical advancements, including the first bone marrow transplants in mammals and the discovery of the hormone leptin. Research conducted at the laboratory, which maintains over 3,000 employees globally, is associated with at least 26 Nobel Prizes in Physiology or Medicine.
According to Cold Spring Harbor Laboratory Preprints, the study is hosted via bioRxiv. The authors said that the license terms for this preprint version do not permit archiving in the PubMed Central database.
Related reading